Literature DB >> 6125896

Studies on the long term effects of SK&F 29661 upon adrenal catecholamines.

R G Pendleton, G Gessner, J Sawyer, L Hillegass, D A Miller.   

Abstract

SK&F 29661 (1,2,3,4-tetrahydro-7-isoquinoline-sulfonamide) is a potent and selective in vitro and in vivo inhibitor of adrenal phenylethanolamine N-methyltransferase (PNMT; EC 2.1.1.28). Its Ki value for in vitro inhibition of rat adrenal PNMT was 133 nM. In vivo, the adrenal conversion of 3H-norepinephrine to 3H-epinephrine was maximally inhibited by a single oral dose of 100 mg/kg. In long term chronic studies in rats, adrenal epinephrine was reduced by SK&F 29661 in a dose dependent fashion to greater than 90%, without substantial increases in norepinephrine. Urinary excretion of epinephrine was significantly reduced by the drug both basally and following 2-deoxy-D-glucose stimulation. No drug related changes were found in plasma corticosterone values and only small effects were observed on adrenal tyrosine hydroxylase and PNMT enzyme levels. The cardiac norepinephrine pool and its turnover time were both significantly reduced; its turnover rate, however, was only slightly increased. Our studies indicate that SK&F 29661 is a highly effective, non-toxic and novel pharmacological tool which is useful in depleting adrenal epinephrine stores via inhibition of its biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6125896     DOI: 10.1007/bf00491473

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  15 in total

1.  Purification and properties of phenylethanolamine-N-methyl transferase.

Authors:  J AXELROD
Journal:  J Biol Chem       Date:  1962-05       Impact factor: 5.157

2.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

3.  The effects of an inhibitor of phenylethanolamine N-methyltransferase upon stimulated adrenal catecholamine release and excretion in the rat.

Authors:  R G Pendleton; G Weiner; B Jenkins; G Gessner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-04       Impact factor: 3.000

4.  Studies on SK&F 29661, an organ-specific inhibitor of phenylethanolamine N-methyltransferase.

Authors:  R G Pendleton; G Gessner; G Weiner; B Jenkins; J Sawyer; W Bondinell; A Intoccia
Journal:  J Pharmacol Exp Ther       Date:  1979-01       Impact factor: 4.030

5.  Studies on the turnover and synthesis of epinephrine from norepinephrine in the adrenal gland.

Authors:  R G Pendleton; I B Snow; G Gessner; H Green
Journal:  Arch Int Pharmacodyn Ther       Date:  1973-06

6.  The blockade of alpha 2-adrenoceptors by the PNMT inhibitaor SK&F 64139.

Authors:  M Goldstein; M Saito; J Y Lew; J P Hieble; R G Pendleton
Journal:  Eur J Pharmacol       Date:  1980-10-17       Impact factor: 4.432

7.  Inhibition of transmethylations of biogenic amines by S-adenosylhomocysteine. Enhancement of transmethylation by adenosylhomocysteinase.

Authors:  T Deguchi; J Barchas
Journal:  J Biol Chem       Date:  1971-05-25       Impact factor: 5.157

8.  Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition.

Authors:  T Chou
Journal:  Mol Pharmacol       Date:  1974-03       Impact factor: 4.436

9.  Substrate specificity of phenethanolamine N-methyl transferase.

Authors:  R W Fuller; J M Hunt
Journal:  Biochem Pharmacol       Date:  1965-12       Impact factor: 5.858

10.  Comparison of the effects of SK & F 29661 and 64139 upon adrenal and cardiac catecholamines.

Authors:  R G Pendleton; G Gessner; J Sawyer
Journal:  Eur J Pharmacol       Date:  1980-11-21       Impact factor: 4.432

View more
  1 in total

1.  The Adrenal Medulla Modulates Mechanical Allodynia in a Rat Model of Neuropathic Pain.

Authors:  Marina Arribas-Blázquez; Luis Alcides Olivos-Oré; María Victoria Barahona; Aneta Wojnicz; Ricardo De Pascual; Mercedes Sánchez de la Muela; Antonio G García; Antonio R Artalejo
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.